Britannia Life Sciences Inc. (BLAB.CN) Research

Britannia Life Sciences Inc., headquartered in Toronto, Canada, offers specialized services in rigorous product evaluation, comprehensive safety analysis, and adherence to regulatory standards. The company supports businesses within the cosmetics, nutraceutical, and consumer packaged goods (CPG) sectors, operating extensively throughout the United Kingdom and various international markets.

Market snapshot

Symbol
BLAB.CN
Price
$0.08
Day change
-6.25%
Market cap
$12.2M
P/E ratio
0.59x
52-week range
0.06-0.14
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Rapid Dose Therapeutics Corp. (DOSE.CN)
  • Hemostemix Inc. (HEM.V)
  • Pharmala Biotech Holdings Inc. (MDMA.CN)
  • Marvel Biosciences Corp. (MRVL.V)
  • Pangenomic Health Inc. (NARA.CN)
  • PharmaTher Holdings Ltd. (PHRM.CN)
  • PreveCeutical Medical Inc. (PREV.CN)
  • Red White & Bloom Brands Inc. (RWB.CN)

Open Britannia Life Sciences Inc. (BLAB.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.